期刊文献+

端粒酶含量测定在宫颈癌发展及预后中的意义 被引量:1

下载PDF
导出
摘要 目的:检测宫颈上皮内瘤样病变(Cervical intraepitheual neoplasia,CIN)及各期宫颈癌组织中端粒酶的含量,探讨端粒酶含量改变作为宫颈癌的早期诊断,治疗及术后复发依据的可能性。方法:采用异硫氰酸荧光素(Fluo- rescein isothiocyanate,FITC)间接荧光标记法对端粒酶进行标记后,流式细胞仪进行定量检测。以端粒酶表达率及端粒酶表达的荧光指数为指标进行统计学分析。以正常宫颈组织为对照。结果:端粒酶表达的百分率及荧光指教两指标在宫颈漫润癌,CIN及正常对照的组间差异显著,且有渐减规律;宫颈癌不同期别的组间差异显著。结论:端粒酶含量在癌前病变中已表现出显著升高,且其含量随肿瘤的发展而进行性升高,因此,端粒酶的定量检测有可能成为宫颈上皮内瘤样病变进展及宫颈癌预后判断的辅助指标。
机构地区 大同大学医学院
出处 《实用医技杂志》 2007年第26期3592-3593,共2页 Journal of Practical Medical Techniques
  • 相关文献

参考文献5

二级参考文献11

  • 1Pao C C,J Clinic Oncol,1997年,15卷,5期,1932页
  • 2Wan M H,J Natl Cancer Ins,1997年,89卷,6期,437页
  • 3乐杰,妇产科学(第4版),1995年,277页
  • 4糜若然,瞿全新.妇科肿瘤基因诊断与治疗[M].北京:人民卫生出版社,1999.74.
  • 5Yashima K, Ashtag R, Nowak J, et al. Telomerase activity and expreosior of ito RNA component in cervical lesions[J].Cancer, 1998,82:1319 - 1327.
  • 6Pao CC, Tsang C J, Lin CY, et al. Differential expression of tailomerase acrivity in human cervical cancer and cervical intraepithelial neoplasia lesions [ J ]. J Clin Oncol, 1997, 15:1932 - 1937.
  • 7Van Bos AB, Van Ballegooijen M, Oortmarssen GJ,et al.Non-progression of cervical intraepithelial neoplasia estimated from population-screening data [J]. Br J Cancer, 1997,75:124 - 130.
  • 8Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up[J]. Obstet Gynecol, 1986,67 :665 - 669.
  • 9王淑珍,孙建衡,张伟,金顺钱,王洪平,李茉,金玉生,曲萍,刘毅.子宫颈上皮内瘤变端粒酶活性的研究[J].中华妇产科杂志,2001,36(5):275-277. 被引量:14
  • 10乔玉环,张梦真,史惠蓉.子宫颈癌及其癌前病变组织端粒酶活性的研究[J].中华妇产科杂志,2001,36(8):483-485. 被引量:21

共引文献9

同被引文献17

  • 1欧阳耀灵,范翠芳,居文惠,杨勇,陈登峰.宫颈癌新鲜组织和石蜡包埋组织中端粒酶检测比较[J].中国优生与遗传杂志,2007,15(1):31-31. 被引量:1
  • 2JEMAL A, SIEGEL R, XU Jia-quan, et al. Cancer statistics, 2010 [J]. CA - A Cancer Journal for Clinicians, 2010, 60(5) : 277 - 300.
  • 3FAN Yi-bo, WU Xin, FU Zhi-min, et al. Amplification of the human telomerase gene in liquid - based preparations is associated with cervical dysplasia and carcinoma [ J]. International Journal of Gynecological Pathology : Official Journal of the International Society of Gvnecolo~,ical Pathologists. 2010. 29 ( 2 ) : 157 - 164.
  • 4ANDERSSON S, SOWJANYA P, WANGSA D, et al. Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormalPap smears [J]. The American Journal of Pathology, 2009, 175 (5) : 1831 - 1847.
  • 5LEVSKY J M, SINGER R H. Fluorescence in situ hybridization: past, present and future[J].Journal of Cell Science, 2003, 116 (14) : 2833 -2838.
  • 6ANDERSSON S, WALLIN K L, HELLSTROM A C, et al. Frequent gain of the human telomerase gene TERC at 3q26 in cervical ad [J]. British Journal of Cancer, 2006, 95(3) : 331 -338.
  • 7WILTING S M, VAN BOERDONK R A, HENKEN F E, et al. Methylation - mediated silencing and tumour suppressive function of hsa- miR- 124 in cervical cancer [J].Molecular Cancer, 2010, 9: 167.
  • 8HESELMEYER - HADDAD K, SOMMERFELD K, WHITE N M, et al. Genomic amplification of the human telomerase gene ( TERC ) in pap smears predicts the development of cervical cancer [ J]. The American Journal of Pathology, 2005, 166 (4) : 1229 - 1238.
  • 9PARK T W, RIETHDORF S, SCHULZ G, et al. Clonal expansion and HPV - induced immortalization are early molecular alterations in cervical carcinogenesis [J].Anticancer Research, 2003, 23(1A) : 155 -160.
  • 10YANGY-c, SHYONG W Y, CHANG M-s, et al. Frequent gain of copy number on the long arm of chromosome 3 in human cervical ad [ J]. Cancer Genetics and Cytogenetics 2001, 131(1) : 48 -53.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部